Pro-protein convertase subtilisin/kexin type 9 promotes intestinal tumor development by activating Janus kinase 2/signal transducer and activator of transcription 3/SOCS3 signaling in Apc(Min/+) mice

INTRODUCTION: Pro-protein convertase subtilisin/kexin type 9 (PCSK9) regulates lipoprotein homeostasis in humans. Evolocumab is a selective PCSK9 inhibitor that can reduce low-density lipoprotein cholesterol (LDLC) level and decrease hypercholesterolemia. The current study aimed to explore whether P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kai, Zhu, Jie, Luo, Huan-hua, Yu, Shu-wen, Wang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485261/
https://www.ncbi.nlm.nih.gov/pubmed/34586888
http://dx.doi.org/10.1177/20587384211038345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485261/
https://www.ncbi.nlm.nih.gov/pubmed/34586888
http://dx.doi.org/10.1177/20587384211038345

Ejemplares similares